HomeREGULATORY
REGULATORY

Japan Eyes Economic Assessments for New Drug Listing: Draft Honebuto Paper
(Jun.6.2018)

The Japanese government intends to consider the use of economic evaluations, such as cost-effective assessments (CEAs), upon the listing of new drugs and new medical technologies, according to a draft paper for this year’s “honebuto” economic and fiscal policy blueprint ...
(LOG IN FOR FULL STORY)

News Calendar